Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare
Aurinia Pharmaceuticals Inc. Operating Income 2018–2025
Aurinia Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aurinia Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 41.4 M, a 89.60% increase year-over-year.
- Aurinia Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 113.1 M, a 686.57% decrease year-over-year.
- Aurinia Pharmaceuticals Inc. annual operating income for 2025 was 104.9 M, a 2338.40% decrease from 2024.
- Aurinia Pharmaceuticals Inc. annual operating income for 2024 was -4.7 M, a 94.89% decrease from 2023.
- Aurinia Pharmaceuticals Inc. annual operating income for 2023 was -91.7 M, a 17.74% decrease from 2022.
- Aurinia Pharmaceuticals Inc. annual operating income for 2022 was -111.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aurinia Pharmaceuticals Inc. Operating Income — FAQ
Aurinia Pharmaceuticals Inc. (AUPH) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Aurinia Pharmaceuticals Inc.'s operating income?
Aurinia Pharmaceuticals Inc. (AUPH) reported operating income of $105M for fiscal 2025.
Where can I see AUPH's operating income history?
The chart and table above show Aurinia Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.